SGLMDA: A Subgraph Learning-Based Method for miRNA-Disease Association Prediction

被引:0
作者
Ji, Cunmei [1 ]
Yu, Ning [1 ]
Wang, Yutian [1 ]
Ni, Jiancheng [2 ]
Zheng, Chunhou [3 ]
机构
[1] Qufu Normal Univ, Sch Software, Qufu 273165, Shandong, Peoples R China
[2] Qufu Normal Univ, Sch Comp Sci & Technol, Qufu 273165, Shandong, Peoples R China
[3] Anhui Univ, Sch Artificial Intelligence, Hefei 230601, Peoples R China
基金
中国国家自然科学基金;
关键词
Subgraph learning; graph representation learning; graph neural networks; microRNA-disease association prediction; CHAOS GAME REPRESENTATION; SIMILARITY; MICRORNAS;
D O I
10.1109/TCBB.2024.3373772
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNA) are endogenous non-coding RNAs, typically around 23 nucleotides in length. Many miRNAs have been founded to play crucial roles in gene regulation though post-transcriptional repression in animals. Existing studies suggest that the dysregulation of miRNA is closely associated with many human diseases. Discovering novel associations between miRNAs and diseases is essential for advancing our understanding of disease pathogenesis at molecular level. However, experimental validation is time-consuming and expensive. To address this challenge, numerous computational methods have been proposed for predicting miRNA-disease associations. Unfortunately, most existing methods face difficulties when applied to large-scale miRNA-disease complex networks. In this paper, we present a novel subgraph learning method named SGLMDA for predicting miRNA-disease associations. For miRNA-disease pairs, SGLMDA samples K-hop subgraphs from the global heterogeneous miRNA-disease graph. It then introduces a novel subgraph representation algorithm based on Graph Neural Network (GNN) for feature extraction and prediction. Extensive experiments conducted on benchmark datasets demonstrate that SGLMDA can effectively and robustly predict potential miRNA-disease associations. Compared to other state-of-the-art methods, SGLMDA achieves superior prediction performance in terms of Area Under the Curve (AUC) and Average Precision (AP) values during 5-fold Cross-Validation (5CV) on benchmark datasets such as HMDD v2.0 and HMDD v3.2. Additionally, case studies on Colon Neoplasms and Triple-Negative Breast Cancer (TNBC) further underscore the predictive power of SGLMDA.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 46 条
  • [1] Bartel D.P., MicroRNAs: Genomics, biogenesis, mechanism, and function, Cell, 116, 2, pp. 281-297, (2004)
  • [2] Bartel D.P., Metazoan MicroRNAs, Cell, 173, 1, pp. 20-51, (2018)
  • [3] Ambros V., The functions of animal microRNAs, Nature, 431, 7006, pp. 350-355, (2004)
  • [4] Gebert L.F., Macrae I.J., Regulation of microRNA function in animals, Nature Rev. Mol. Cell Biol., 20, 1, pp. 21-37, (2019)
  • [5] Carthewand R.W., Sontheimer E.J., Origins and mechanisms of miRNAs and siRNAs, Cell, 136, pp. 642-655, (2009)
  • [6] Chou C.H., Et al., MiRTarBase 2016: Updates to the experimentally validatedmiRNA-target interactions database, Nucleic Acids Res., 44, pp. D239-D247, (2016)
  • [7] Li Y., Et al., HMDDv2.0: A database for experimentally supported human microRNA and disease associations, Nucleic Acids Res., 42, pp. D1070-D1074, (2014)
  • [8] Huang Z., Et al., HMDD v3.0: A database for experimentally supported human microRNA-disease associations, Nucleic Acids Res., 47, pp. D1013-D1017, (2019)
  • [9] Toyoshima K., Oncogenes and cancer, Nippon Geka Gakkai Zasshi, 90, 6, pp. 805-809, (1989)
  • [10] Ha M., Kim V.N., Regulation of microRNA biogenesis, Nature Rev. Mol. Cell Biol., 15, 8, pp. 509-524, (2014)